Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 22 Jul 2025 01:30 CEST |
BIOGEN | Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025 | - | - |
| 12 Jun 2025 07:00 CEST |
BIOGEN | Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity | - | - |
| 19 Nov 2024 07:00 CET |
BIOGEN | Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity | - | - |
| 24 Sep 2024 07:00 CEST |
BIOGEN | UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024 | - | - |